Show simple item record

dc.contributor.authorCui, Guanglin
dc.contributor.authorYuan, Aping
dc.contributor.authorPang, Zhigang
dc.contributor.authorFlorholmen, Jon
dc.date.accessioned2023-10-19T10:47:41Z
dc.date.available2023-10-19T10:47:41Z
dc.date.created2023-04-19T18:42:13Z
dc.date.issued2023
dc.identifier.citationCui, G., Yuan, A., Pang, Z., & Florholmen, J. (2023). Differential profile of protumor immunological factors between the tumor site and the tumor-free site – predictive potential of IL-8 and COX2 for colorectal cancer and metastasis. International Immunopharmacology, 118, Article 110089. doi:en_US
dc.identifier.issn1878-1705
dc.identifier.urihttps://hdl.handle.net/11250/3097540
dc.descriptionAuthor's accepted version (postprint).en_US
dc.descriptionThis is an Accepted Manuscript of an article published by Elsevier in International Immunopharmacology on 5/4/2023.en_US
dc.descriptionAvailable online: https://doi.org/10.1016/j.intimp.2023.110089en_US
dc.language.isoengen_US
dc.publisherElsevieren_US
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/deed.no*
dc.titleDifferential profile of protumor immunological factors between the tumor site and the tumor-free site – predictive potential of IL-8 and COX2 for colorectal cancer and metastasisen_US
dc.typePeer revieweden_US
dc.typeJournal articleen_US
dc.description.versionacceptedVersionen_US
dc.rights.holder© 2023 Elsevier B.V.en_US
dc.source.pagenumber8en_US
dc.source.volume118en_US
dc.source.journalInternational Immunopharmacologyen_US
dc.identifier.doi10.1016/j.intimp.2023.110089
dc.identifier.cristin2141944
dc.relation.projectNorthern Norway Regional Health Authority: SFP-44-04en_US
dc.source.articlenumber110089en_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 Internasjonal
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 Internasjonal